Stoke Therapeutics, Inc.
STOK
FAIR PRICE VALUATION
Updated daily
Model: DCF 50% · Relative 30% · Consensus 20%
MARKET PRICE
$33.40
FAIR PRICE
$21.77
MARGIN
$11.63
P/E Ratio
50.0x
Div. Yield
N/A
ROE
13.3%
Market Cap
$2B
Small-cap
COMING SOON
Get notified when STOK's fair price changes
Fair Price Index app is launching soon with push notifications when valuations shift for stocks you follow.
iOS and Android · Free tier available
KEY FACTS
CEO
Ian F. Smith
COUNTRY
US
HEADQUARTERS
Bedford
SECTOR
Healthcare
EXCHANGE
NASDAQ
METHODOLOGY
How we calculate STOK's fair price
Stoke Therapeutics, Inc.'s fair price of $21.77 is derived from a blended model that combines DCF analysis (50%), relative valuation against Healthcare peers (30%), and analyst consensus (20%). At the current market price of $33.40, STOK trades 34.8% above its calculated fair value. The stock's P/E of 50.0x is a key input in the relative valuation component.
DCF MODEL · 50%
Discounted cash flow analysis based on projected free cash flows, discounted at a rate reflecting STOK's risk profile.
RELATIVE · 30%
Comparing STOK's valuation multiples against Healthcare peers.
ANALYST · 20%
Aggregated analyst price targets for STOK, weighted by recency and analyst accuracy.
POWERED BY BULIOS
Get full analysis, financials, and AI insights for STOK.
Explore on BuliosFAQ
What is the fair price of STOK?+
Based on our blended model combining DCF analysis (50%), relative valuation against Healthcare peers (30%), and analyst consensus (20%), the fair price for Stoke Therapeutics, Inc. is $21.77. At the current market price of $33.40, STOK trades 34.8% above its calculated fair value.
Is STOK overvalued or undervalued?+
Stoke Therapeutics, Inc. is currently overvalued based on our valuation model. The stock trades at $33.40, which is 34.8% above the fair price of $21.77. The P/E ratio of 50.0x is a key metric in the valuation.
How often is STOK's fair price updated?+
We update fair price calculations for STOK daily after market close. The current fair price of $21.77 incorporates the latest market data and sector multiples.
What factors affect STOK's fair price calculation?+
STOK's fair price of $21.77 is derived from DCF analysis (50% weight), relative valuation against Healthcare peers (30% weight), and analyst consensus (20% weight). Key metrics include P/E of 50.0x, ROE of 13.3%.
Is STOK a good buy right now?+
At $33.40, STOK trades 34.8% above our fair value estimate of $21.77. The stock is currently overvalued. ROE stands at 13.3% (average). Fair Price Index provides valuation data — always do your own research before investing.
Does STOK pay dividends?+
STOK does not currently pay a dividend.